Our findings indicate that ADCYAP1R1, GPI, and NTS may contribute to a poor prognosis in melanoma patients, while IFITM1, KIR2DL4, and LIF are more likely to be associated with a better prognosis in individuals with melanoma. Here, KIR2DL4 is linked to melanoma.